Cushing’s Syndrome Therapeutics Analysis, Clinical Trials and Developments

Cushing’s syndrome therapeutics currently exhibits a proliferating pipeline with 15+ therapeutic candidates. Overproduction of cortisol hormone leads to Cushing’s syndrome. Also, exposure to glucocorticoids is expected to be one of the prime causes of the disease. Glucocorticoids are usually prescribed Read more ›